Spot Diagnosis Skin Health Institute

More and more frequently we hear the term ‘skin of colour’ being used colloquially and in medicine. What exactly do we mean by the term ‘skin of colour’? Why are patients with ‘skin of colour’ considered different, unique or distant from societal norms? In this episode, dermatologist Dr Ahmed Kazi passionately educates the listener about how and why common skin conditions present differently in patients with skin of colour, and variations in the natural history of these conditions.
See omnystudio.com/listener for privacy information.

The latest episode, Skincare Gone Crazy, delves into the growing obsession with skincare among today’s youth and its potential physical and psychological repercussions, providing parents and practitioners with valuable insights and the latest information from top clinicians. 
We have a distinguished panel of experts including consultant dermatologists, Dr Mei Tam and Dr Katherine Armour, consultant psychiatrist Dr Siu-Ying Kwok and GP Dr Laxmi Iyengar.
See omnystudio.com/listener for privacy information.

In honour of HS Awareness Week, we had consultant dermatologist and lead consultant of the Skin Health Institute HS Clinic, Dr Diana Norris join us on the Spot Diagnosis Podcast to delve into the complex condition that is hidradenitis suppurativa (HS).
HS can be challenging to diagnose and manage, and it is pivotal to address both the physical and psychological aspects of the condition to optimise patient care.
In this episode, we clarify misconceptions and discuss clinical cases to provide valuable insights into the various HS presentations and treatment approaches, helping to improve understanding and outcomes for individuals affected by HS.
https://skinhealthinstitute.org.au/spot-diagnosis/clinical-cases-in-hidradenitis-suppurativa/
See omnystudio.com/listener for privacy information.

In this episode, we delve into the crucial role clinical trials play in advancing dermatological treatments and enhancing skin health. Clinical trials are essential for demonstrating the effectiveness and safety of new treatments and interventions to prevent, detect, treat, or manage various medical conditions. They are key to improving our current disease management methods and shaping future medical practices.
We examine the unique aspects of dermatological clinical trials, the challenges they encounter, and the breakthroughs they achieve.
Our panel of experts for this episode includes, Director of Research at the Skin Health Institute, A/Prof Peter Foley, Director of Clinical Research & Advanced Targeted Therapies at the Skin Health Institute, Ms Sarah Chivers and Deputy Director of Research at St Vincent’s Hospital Melbourne, A/Prof Tam Nguyen. 
For more information on this episode or to access resources, visit the link below.
https://skinhealthinstitute.org.au/spot-diagnosis/clinical-trials/ 
See omnystudio.com/listener for privacy information.

In this episode, we delve into a comparison between two prevalent skin issues: periorificial dermatitis and seborrheic dermatitis. We explore the factors associated with periorificial dermatitis, such as frequent use of layered cosmetics, prolonged application of potent topical steroids, and wearing masks. In contrast, seborrheic dermatitis manifests in areas abundant in sebaceous glands, where skin's natural inhabitants like Malassezia Furfur break down fatty acids in sebum, leading to skin inflammation.
See omnystudio.com/listener for privacy information.

In this episode, we explore the interrelationship between diseases affecting the gut and the skin, in other words, cutaneous manifestations of gastrointestinal disease.
We discuss the pathophysiology of coeliac disease, inflammatory bowel disease and common skin conditions such as acne and explore how and why these conditions clinically manifest in the skin.
For more information on this episode and to access the resources, click the link below:
https://skinhealthinstitute.org.au/spot-diagnosis/the-skin-and-the-gut/
 
 
See omnystudio.com/listener for privacy information.